Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | NPY1R | P25929 | 1/20 | 0.33 |
| ▸ | AKT1 | P31749 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | JAK1 | P23458 | 1/20 | 0.30 |
| ▸ | JAK3 | P52333 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26961849 | 0.85 | DGAT1 (0.37) | DGAT1 | |
| SCHEMBL26961664 | 0.85 | GCGR (0.35) | NPY1RHDAC6 | |
| SCHEMBL26962398 | 0.84 | HDAC6 (0.36) | NPY1RAKT1HDAC6 | |
| SCHEMBL26961640 | 0.83 | NPY1R (0.35) | NPY1RHDAC6 | |
| SCHEMBL26961619 | 0.83 | NPY1R (0.32) | NPY1RHDAC6 | |
| SCHEMBL26961717 | 0.80 | HDAC6 (0.34) | NPY1RHDAC6 | |
| SCHEMBL26962136 | 0.78 | CNR2 (0.36) | NPY1R | |
| SCHEMBL26961788 | 0.78 | CNR2 (0.34) | NPY1R | |
| SCHEMBL26961913 | 0.77 | CNR2 (0.34) | NPY1R | |
| SCHEMBL26961397 | 0.77 | DGAT1 (0.37) | DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4291558-A1 | BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER | F. Hoffmann-La Roche AG (CH) | 2023-12-20 | — | — | EP | disclosed |